Showing results (11-20 of 288) with videos related to
Sort By:
Pageof 29
Rambam Maimonides Medical Journal|November 12, 2014
Genetic stratification in myeloid diseases: from risk assessment to clinical decision support toolYishai OfranCurrent Opinion in Hematology|December 31, 2015
Is the D14 bone marrow in acute myeloid leukemia still the gold standard?Yishai OfranHaematologica|October 5, 2019
How I diagnose and manage Philadelphia chromosome-like acute lymphoblastic leukemiaAvraham Frisch, Yishai OfranBlood Reviews|September 26, 2016
BCR-ABL (Ph)-like acute leukemia-Pathogenesis, diagnosis and therapeutic optionsYishai Ofran, Shai IzraeliFrontiers in Medicine|November 28, 2022
Implementation of data protection laws in the European Union and in California is associated with a move of clinical trials to countries with fewer data protectionsElad Yom-Tov, Yishai OfranHaematologica|May 28, 2026
Is CPX-351 the best path to remission for older patients with treatment-related or myelodysplastic-related acute myeloid leukemia?Meira Yisraeli-Salman, Yishai OfranBritish Journal of Haematology|December 25, 2024
CPX-351 +/- gemtuzumab ozogamicin as induction therapy for adult patients with newly diagnosed, favourable-intermediate risk, FLT3-ITD negative, AML: A pilot studyChezi Ganzel, Avraham Frisch, Ofir Wolach, et al.Experimental Hematology|December 24, 2021
Anti-CD20 monoclonal antibodies inhibit seropositive response to Covid-19 vaccination in non-Hodgkin lymphoma patients within 6 months after treatmentAriella Tvito, Aaron Ronson, Renan Ghosheh, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 8, 2016
Adult Nephrotic Syndrome after Hematopoietic Stem Cell Transplantation: Renal Pathology is the Best Predictor of Response to TherapyOfrat Beyar-Katz, Etty Kruzel Davila, Tsila Zuckerman, et al.Pageof 29